3,511 results found

Celgene obtained data protection (innovative drug status) for THALOMID® brand drug (thalidomide). In a decision released February 6, 2012, the Federal Court granted Celgene's application for judicial review against the Minister's decision to refuse data protection to Celgene in respect of THALOMID® brand drug (thalidomide).

The Federal Court has dismissed a request to certify a proposed class proceeding against a large number of generic...

On November 20, 2019, the Federal Court (FC) issued its reconsideration decision on the quantum of damages owed by Apotex for its infringement of eight Eli Lilly process...

Catalyst Pharmaceuticals, Inc (Catalyst) filed a new drug submission (NDS) for FIRDAPSE one month before Médunik filed its NDS for RUZURGI.

On June 12, 2019, Justice Gleeson dismissed Alexion's application for judicial review of a Panel of the Patented Medicines Price Review Board (PMPRB)'s (i) decision

The 2008 Canadian Listeriosis outbreak that was linked to cold cuts from a Maple Leaf Foods plant in Toronto, Ontario resulted in 57 confirmed cases and 22 deaths. I

Canada’s food laws are undergoing a major overhaul.

Promoting and branding cannabis is one of the most important pillars supporting the shift from an illicit market to a legal market.

On October 5, 2022, Alberta announced amendments (the "Amendments") to the Mental Health Services Protection Regulation, which are expected to come into effect on January 16, 2023.

Following on Health Canada's plan to introduce new regulations aimed at addressing therapeutic product shortages as discussed previously...

In response to stakeholder concerns about outdated and overly prescriptive administrative processes, the Government of Canada launched a review of administrative burdens...

Canada's new Prime Minister continues to make waves on the global stage.

On December 28, 2024, Health Canada published proposed amendments to the Food and Drug Regulations and Medical Devices Regulations to address therapeutic product shortages...

•The scope and application of section 5 of Regulations, including providing clarification for the types of submissions that will be captured by the provision when a second person applies for an NOC.

Health Canada has published a report on its public consultation on building a national strategy to address access to drugs for rare diseases.

​Legal cannabis in Canada is still in its infancy, but the rate of growth has been revolutionary.

A discussion on the story that a Prof. Seralini at Caen University had proven that GMOs are "poison."

When marijuana is legal next year, you won't be able to get it from those so called "dispensaries" that have been popping up around the GTA.